Mannose-6-Phosphate Receptor: A Target for Theranostics of Prostate Cancer

A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer

(2014) Vittorio de Franciscis   MOLECULAR THERAPY

Development and Characterization of an Antibody-Labeled Super-Paramagnetic Iron Oxide Contrast Agent Targeting Prostate Cancer Cells for Magnetic Resonance Imaging

(2014) David Bates et al.   PLoS One

Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy

(2012) Magali Gary-Bobo et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Mannose-Functionalized Mesoporous Silica Nanoparticles for Efficient Two-Photon Photodynamic Therapy of Solid Tumors

(2011) Magali Gary-Bobo et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

New Strategies for Enzyme Replacement Therapy for Lysosomal Storage Diseases

(2010) Jeffrey H. Grubb et al.   REJUVENATION RESEARCH

Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy

(2009) David Brevet et al.   CHEMICAL COMMUNICATIONS

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Photodynamic therapy for prostate cancer—a review of current status and future promise

(2009) Caroline M Moore et al.   Nature clinical practice. Urology

Synthesis of new sulfonate and phosphonate derivatives for cation-independent mannose 6-phosphate receptor targeting

(2008) Audrey Jeanjean et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Screening for prostate cancer (PC)—an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC)

(2008) Fritz H. Schröder   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Evaluating Localized Prostate Cancer and Identifying Candidates for Focal Therapy

(2008) A. Oliver Sartor et al.   UROLOGY